Benitec Biopharma Statistics, Revenue Totals and Facts (2021)

Here are a few of the most interesting Benitec Biopharma statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Benitec Biopharma Facts

  • Website: Official Website
  • Year Founded: 1997
  • Headquarters: Melbourne, Australia
  • Founder(s): Michael Graham
  • Current Chief Executive: Jerel Banks

What is Benitec Biopharma?

Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates for the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B. By combining the specificity and gene silencing effect of RNAi with gene therapy, ddRNAi has the potential to produce long-lasting silencing of disease-causing genes from a single administration, which could minimize the requirement for patients to take regular doses of medicine. (source)

Benitec Biopharma Employee Count

Number of Benitec Biopharma employees:

21 employees

Last updated 7/1/19

Benitec Biopharma Revenue Totals

Benitec Biopharma annual revenue:

Benitec Biopharma annual net income:

Please note that some of these numbers are easier to find than others. A few of these Benitec Biopharma stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.